Generic drugs approved by FDA (through November 2008) including galantamine extended-release capsules and carbidopa/levodopa orally disintegrating tablets
Galantamine extended-release capsules, 8, 16, and 24 mg equiv base (equiv to Razadyne ER)
BARR
Carbidopa/levodopa orally disintegrating tablets, 10/100, 25/100, and 25/250 mg (equiv to Parcopa)
MYLAN
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.